Guaragna Mara Sanches, Lutaif Anna Cristina G B, Piveta Cristiane S C, Souza Marcela L, de Souza Suéllen R, Henriques Taciane B, Maciel-Guerra Andréa T, Belangero Vera M S, Guerra-Junior Gil, De Mello Maricilda P
Centro de Biologia Molecular e Engenharia Genética, Universidade Estadual de Campinas, Campinas, São Paulo, Caixa Postal 6010, Brasil.
Nefrologia Pediátrica, Departamento de Pediatria, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, São Paulo, Brasil.
BMC Med Genet. 2015 Sep 29;16:88. doi: 10.1186/s12881-015-0231-9.
Nephrotic syndrome is traditionally classified on the basis of the response to standard steroid treatment. Mutations in more than 24 genes have been associated with nephrotic syndrome in children, although the great majority of steroid-resistant cases have been attributed to mutations in three main genes: NPHS1, NPHS2 and WT1. The aims of this study were to identify mutations in these genes more frequently reported as mutated and to characterize each variation using different in silico prediction algorithms in order to understand their biological functions.
We performed direct sequence analysis of exons 8 and 9 of WT1, 8 exons of NPHS2 and 29 exons of NPHS1, including NPHS2 and NPHS1 intron-exon boundary sequences, as well as 700 bp of the 5' UTR from both genes in 27 steroid-resistant patients aged between 3 months and 18 years.
Analysis of the NPHS2 gene revealed four missense mutations, one frameshift mutation and three variations in the 5' UTR. Four patients presented compound heterozygosis, and four other patients presented one heterozygous alteration only. WT1 and NPHS1 gene analysis did not reveal any mutations.
This is the first study focusing on genetics of SRNS in Brazilian children. Identification of mutations is important because it could influence physicians' decision on patient treatment, as patients carrying mutations can be spared the side effects of immunosuppressive therapy and ultimately could be considered for kidney transplantation from a living donor.
After molecular analysis of the genes more frequently reported as mutated in 27 steroid-resistant nephrotic syndrome patients, we identified NPHS2 mutations confirming the hereditary character of the kidney disease in only 14.8% of patients. Therefore, the next step is to perform a next generation sequencing based analysis of glomeluropathy-related panel of genes for the remaining patients in order to search for mutations in other genes related to steroid-resistant nephrotic syndrome.
传统上,肾病综合征是根据对标准类固醇治疗的反应进行分类的。超过24个基因的突变与儿童肾病综合征有关,尽管绝大多数类固醇抵抗病例归因于三个主要基因的突变:NPHS1、NPHS2和WT1。本研究的目的是识别这些更常被报道发生突变的基因中的突变,并使用不同的计算机预测算法对每个变异进行表征,以了解其生物学功能。
我们对27名年龄在3个月至18岁之间的类固醇抵抗患者的WT1基因的第8和第9外显子、NPHS2基因的8个外显子和NPHS1基因的29个外显子进行了直接序列分析,包括NPHS2和NPHS1基因的内含子-外显子边界序列,以及两个基因5'UTR的700bp序列。
对NPHS2基因的分析发现了四个错义突变、一个移码突变和5'UTR中的三个变异。四名患者表现为复合杂合子,另外四名患者仅表现为一个杂合改变。WT1和NPHS1基因分析未发现任何突变。
这是第一项关注巴西儿童SRNS遗传学的研究。突变的识别很重要,因为它可能影响医生对患者治疗的决策,因为携带突变的患者可以避免免疫抑制治疗的副作用,最终可以考虑接受活体供体的肾脏移植。
在对27名类固醇抵抗性肾病综合征患者中更常被报道发生突变的基因进行分子分析后,我们发现NPHS2突变仅在14.8%的患者中证实了肾病的遗传特征。因此,下一步是对其余患者进行基于下一代测序的肾小球病相关基因 panel 分析,以寻找与类固醇抵抗性肾病综合征相关的其他基因中的突变。